Adipotide Dosage Guide, Benefits & Side Effects

Adipotide Dosage Guide, Benefits & Side Effects

Adipotide destroyed adipose blood vessels for rapid fat loss in animal studies, but human trials were halted in 2012 over kidney toxicity concerns.

Chemical Makeup

25

Amino Acids

Adipotide

Cys

Position 1

Lys

Position 2

Gly

Position 3

Position 4

Arg

Position 5

Ala

Position 6

Position 7

Asp

Position 8

Position 9

Position 10

Position 11

Position 12

Leu

Position 13

Position 14

Position 15

Position 16

Position 17

Position 18

Position 19

Position 20

Position 21

Position 22

Position 23

Position 24

Position 25

As seen on

Adipotide Dosage Guide for Fat Loss / MetabolicAdipotide Dosage Calculator

Adipotide (FTPP) is an experimental peptide studied for targeting blood vessels that feed fat tissue, cutting off their supply so fat cells die off. Animal studies showed major fat loss, but early human trials raised kidney safety concerns, halting development.

Vial size

10 mg

Bacteriostatic water

2 mL (yields ~5 mg/mL)

Dosing

250–1,000 mcg

Frequency

Daily

Cycle

4 weeks

Benefit

Fat Loss / Metabolic

What is Adipotide?

Adipotide is an experimental compound that works very differently from most weight-loss peptides: instead of changing hunger or metabolism, it cuts off the blood supply to fat tissue, causing fat cells to die off. In animal studies, including primates, it caused dramatic fat loss. However, human testing was stopped after safety concerns about kidney damage, so it isn't used or available today.

Weight

Research targets include appetite regulation, fat metabolism, and body composition.

adi

Is Adipotide FDA approved?

Adipotide is not an FDA-approved drug. It is intended for research purposes only and is not approved for human consumption, diagnostic, or therapeutic use.

Research Use Only

Adipotide has not been evaluated by the FDA for safety or efficacy in humans.

No Clinical Oversight

Not manufactured under FDA-regulated quality or clinical standards.

Unregulated Sourcing

Purity, dosing, and sourcing are not verified through FDA testing or oversight.

Our top-rated vendor

View all vendors

Our rankings are based solely on third-party lab testing rigor, COA transparency, and pricing — no paid placements, no affiliate influence. We update this list as new data comes in.

Based on current scores, this vendor ranks highest across those criteria.

Protide Health

#1 Rated Research Peptide Supplier

How Does Adipotide Work?

One part of the molecule acts like a homing beacon that finds and attaches to blood vessels feeding fat tissue; the other part then punches holes in those vessel cells' internal power plants. This cuts off blood supply to the fat, causing the fat cells fed by those vessels to die from lack of oxygen.

Homes in on fat vessels

One part of the molecule finds and attaches to blood vessels feeding fat tissue.

Disrupts vessel cells

The other part damages the internal power plants of those vessel cells.

Fat cells die off

Cutting blood supply causes fat cells to die from lack of oxygen.

Adipotide Targeted areas

How to reconstitute Adipotide

The materials you'll need and step-by-step instructions for safely mixing Adipotide with bacteriostatic water.

Materials needed

Your Adipotide vial (lyophilized)

Alcohol swabs

Bacteriostatic sterile water

3 mL syringes (Luer Lock tip)

25G or 27G needles (Luer Lock). Other gauges may also be acceptable.

Sharps container (optional)

Remove the caps

Sanitize the rubber stoppers

Attach the needle

Draw the bac water

Pull back on the plunger to draw your desired volume of bacteriostatic water. If you overfill, just push the excess back in until you reach the right marker on the syringe.

Insert the needle into the Adipotide vial

With the bac water in your syringe, insert the needle into the Adipotide vial at a slight angle to avoid pressure buildup.

Release the water gently

Let the water run gently down the side of the vial. Don't inject it forcefully.

Swirl to dissolve

Avoid shaking. Gently swirl, flip, and roll the vial to dissolve the powder.

Check for full dissolution

Cap, dispose, and store

How to Store Adipotide

The dry powder keeps in the freezer for up to two years, or in the fridge for a few months. Once mixed with liquid, refrigerate and use within two weeks, and avoid repeated freezing and thawing.

Lyophilized Storage

-20°C for up to 2 years, or 2–8°C for up to 3 months.

Reconstituted Storage

2–8°C, use within 14 days.

Handling Notes

Avoid freeze-thaw cycles.

What Are the Benefits of Adipotide?

What research says it may help with, and how it works in the body.

weight loss

By targeting the blood vessels that supply fat tissue, it produced 7 to 15 percent body-weight loss over four weeks in obese monkeys in research studies.

metabolic

After fat loss in primate studies, the body's insulin response improved, meaning less insulin was needed overall.

appetite control

Causes weight loss without primarily suppressing appetite, instead working through its effects on blood vessels feeding fat tissue.

What Are the Side Effects of Adipotide?

Who should avoid it, warning signs to watch for, and what to know before combining it with other compounds.

Who Should Avoid It

Pregnancy/lactation (not studied)

Dehydration

Concurrent nephrotoxic medications

Stop Right Away If You Notice

Sustained creatinine elevation or oliguria

Progressive electrolyte abnormalities

Severe injection-site reactions or systemic symptoms

Unexpected toxicity

Milder Signs to Watch For

How Long Should a Adipotide Cycle Last?

This breaks down how long a typical Adipotide cycle runs and what research suggests happens at each stage. Research shows that staying on a peptide continuously, without a break, may make it less effective over time.

That's why most research protocols build in a break between cycles, often called a washout period, to let the body reset before starting again.

Related peptides

GLP-3

Metabolic

GLP-3 (Retatrutide)

Preclinical

GLP-1

GLP-1 (Semaglutide)

Fda Approved

sur

Survodutide

Phase 3

tesa

Growth

Tesamorelin

Adipotide Research References

It is a phase 1 compound

Adipotide is a phase 1 compound

Rhesus macaques at 0.43 mg/kg SC daily for 28 days showed 7.4-14.7% weight loss; insulin resistance improved; mild, dose-dependent, reversible proximal tubule changes.

2011

Mice with diet-induced obesity showed ~30% weight reduction; adipose vascular apoptosis; metabolic normalization.

2004

Mechanistic validation of prohibitin/ANXA2 axis in adipose tissue, core to TP01 targeting.

2016

Next-generation prohibitin constructs improve serum stability and efficacy vs. first-generation TP01.

2025

Frequently Asked Questions About Adipotide

Straight answers on reconstitution, dosing, and safety, everything you need to research with confidence. For research reference only.

What is Adipotide and how does it work?

Adipotide (research code FTPP, chemical sequence CKGGRAKDC-D(KLAKLAK)2) is a synthetic peptibody-style peptide developed by researchers at MD Anderson Cancer Center. It is designed to selectively bind prohibitin, a protein found on the surface of blood vessels that supply white (fat-storing) adipose tissue. Once bound, its attached pro-apoptotic sequence disrupts mitochondria in those vessel cells, triggering programmed cell death (apoptosis), cutting off blood supply to fat tissue, and causing localized fat cell death. Because prohibitin is expressed mainly on white fat vasculature and not brown fat, the mechanism is intended to be tissue-selective rather than a general appetite suppressant or metabolic stimulant.

Is Adipotide approved for human use or legal to take?

No. Adipotide has no FDA approval for any indication and no approved IND, NDA, or BLA filing for weight loss. It reached a Phase 1 clinical trial (sponsored by Arrowhead Research/Arrowhead Pharmaceuticals) evaluating safety in obese patients with castrate-resistant prostate cancer, but no drug based on it has completed development or reached market. In the US it is sold by suppliers only as a research-use-only (RUO) chemical for laboratory and animal research, not for human consumption. Any use in people is off-label, unsupervised, and outside any established medical or regulatory framework.

What does the research actually show about fat loss?

The core evidence comes from a 2011 Science Translational Medicine study in obese rhesus monkeys, which found that after 28 days of dosing, animals lost an average of about 11% of body weight, showed roughly 39% shrinkage of adipose tissue depots, reduced waist circumference, and marked improvements in insulin sensitivity, in some cases within days. These are animal-model results; comprehensive human efficacy data have not been published, and the compound's Phase 1 human trial was designed primarily to assess safety and dosing, not to prove weight-loss efficacy in people.

What side effects or safety concerns have been reported?

The most consistently reported issue across animal studies and early human evaluation is dose-dependent kidney toxicity, described as mild and generally reversible renal tubular injury, along with dehydration and small kidney lesions at higher doses in monkeys. Because there is no completed, published human safety dataset, the full side-effect profile in people (including at what doses toxicity becomes a problem) is not well characterized. Anecdotal reports from research-chemical users mention fatigue and injection-site discomfort, but these are not from controlled studies and should not be treated as an established safety profile.

What dosing protocols do people use for Adipotide?

There is no standardized, clinically validated human dosing protocol. Published animal research used defined mg/kg dosing over cycles (e.g., ~28-day treatment periods) under laboratory conditions with monitoring. Dosing figures circulated in research-chemical communities are typically extrapolated or anecdotal rather than derived from completed human trials, and there is no consensus protocol for frequency, cycle length, or titration. Because of the documented kidney-toxicity signal, any dosing decisions carry meaningful uncertainty and risk without clinical oversight.

How should Adipotide be stored and handled?

As with most lyophilized (freeze-dried) research peptides, unreconstituted Adipotide is generally kept sealed in its original vial, protected from light and moisture, and stored frozen (around -4°F/-20°C or colder) for long-term stability, with short-term refrigeration (about 36-46°F/2-8°C) considered acceptable if the material will be used within a few weeks. Specific reconstitution and stability data for this compound are not well published, so users should rely on the supplier's certificate of analysis and handling guidance rather than assuming standard peptide storage rules guarantee potency or purity.

Why did development of Adipotide stall after promising monkey studies?

Despite strong preclinical results, Adipotide's clinical progress slowed largely because of the kidney-toxicity findings, which limited the dose range that could be pursued safely, and the significant difficulty of demonstrating an acceptable risk-benefit profile for a purely cosmetic/metabolic indication (obesity) using a cytotoxic, vasculature-targeting mechanism. Public reporting has described the compound as having largely fallen off the radar after its initial Phase 1 trial, with no widely publicized follow-on trials or approvals since.

How is Adipotide different from GLP-1 drugs like semaglutide?

Adipotide's mechanism is fundamentally different from GLP-1 receptor agonists. GLP-1 drugs work by affecting appetite, gastric emptying, and insulin secretion through hormone receptor pathways, producing gradual, reversible weight loss that depends on continued dosing. Adipotide instead physically destroys the blood supply to white fat tissue via targeted apoptosis, which in animal studies produced rapid fat loss without the gastrointestinal side effects typical of GLP-1 drugs, but introduces a distinct toxicity risk (kidney injury) and has not been shown to be reversible or safe over long-term human use the way approved GLP-1 medications have.